0001161697-23-000300.txt : 20230517
0001161697-23-000300.hdr.sgml : 20230517
20230517170423
ACCESSION NUMBER: 0001161697-23-000300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230515
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCENANY PATRICK J
CENTRAL INDEX KEY: 0000929985
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 23932680
MAIL ADDRESS:
STREET 1: C/O THERMOGENESIS CORP
STREET 2: 2711 CITRUS ROAD
CITY: RANCHO CORDOVA
STATE: CA
ZIP: 95742
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 05-15-2023
X0407
4
2023-05-15
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0000929985
MCENANY PATRICK J
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
1
1
0
0
President and CEO
0
Common stock, par value $0.001 per share
2023-05-15
4
M
0
26151
0.79
A
3971587
D
Common stock, par value $0.001 per share
2023-05-15
4
S
0
26151
13.23
D
3945436
D
Common stock, par value $0.001 per share
2023-05-16
4
M
0
173849
0.79
A
4119285
D
Options to purchase common stock
0.79
2023-05-15
4
M
0
26151
0
D
2023-06-15
Common Stock
26151
3101516
D
Options to purchase common stock
0.79
2023-05-16
4
M
0
173849
0
D
2023-06-15
Common Stock
173849
2927667
D
Shares were sold to cover tax withholding requirements.
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.20 to $13.285 per share.
Options vested in two equal tranches beginning on June 15, 2017.
/s/ Patrick J. McEnany
2023-05-17